Clinical use of inhaled corticosteroids in asthma. 1996

J B Wasserfallen, and J N Baraniuk
Clinical Economics Research Unit, Georgetown University Medical Center, Washington, D.C., USA.

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

J B Wasserfallen, and J N Baraniuk
March 2001, Pharmacotherapy,
J B Wasserfallen, and J N Baraniuk
January 1999, Allergy and asthma proceedings,
J B Wasserfallen, and J N Baraniuk
September 1997, Pediatric pulmonology. Supplement,
J B Wasserfallen, and J N Baraniuk
October 1999, Drug and therapeutics bulletin,
J B Wasserfallen, and J N Baraniuk
September 2002, The Medical clinics of North America,
J B Wasserfallen, and J N Baraniuk
May 1990, The Medical journal of Australia,
J B Wasserfallen, and J N Baraniuk
July 1994, American journal of respiratory and critical care medicine,
J B Wasserfallen, and J N Baraniuk
April 2003, The Journal of asthma : official journal of the Association for the Care of Asthma,
J B Wasserfallen, and J N Baraniuk
October 1990, Thorax,
J B Wasserfallen, and J N Baraniuk
March 2002, Current allergy and asthma reports,
Copied contents to your clipboard!